AT
GILD icon

American Trust’s Gilead Sciences GILD Stock Holding History

American Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$250K Buy
1,978
+65
+3% +$8.56K 0.02% 276
2026
Q1 		$267K Sell
1,913
-613
-24% -$85.8K 0.02% 247
2025
Q4 		$310K Buy
2,526
+620
+33% +$75.3K 0.03% 232
2025
Q3 		$212K Buy
+1,906
New +$217K 0.02% 305
2025
Q1 		– Sell
-2,369
Closed -$219K – 182
2024
Q4 		$219K Sell
2,369
-24,690
-91% -$2.22M 0.02% 288
2024
Q3 		$2.27M Sell
27,059
-6,167
-19% -$471K 0.19% 73
2024
Q2 		$2.28M Sell
33,226
-3,205
-9% -$214K 0.19% 75
2024
Q1 		$2.67M Buy
36,431
+15
+0% +$1.15K 0.22% 76
2023
Q4 		$2.95M Sell
36,416
-1,013
-3% -$78.8K 0.22% 73
2023
Q3 		$2.8M Buy
37,429
+34,112
+1,028% +$2.62M 0.22% 76
2023
Q2 		$256K Sell
3,317
-170
-5% -$13.6K 0.02% 342
2023
Q1 		$289K Buy
+3,487
New +$289K 0.02% 317

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

American Trust's GILD Position: Q2 2026 in Review

American Trust increased its Gilead Sciences (GILD) stake by 3.4% in Q2 2026, buying an estimated $8.56K and bringing the position to 1,978 shares worth $250K. The position accounts for 0.02% of the portfolio, ranked #276.

American Trust first reported a position in GILD in Q1 2023 and has held it in 12 quarters since. The position peaked at $2.95M in Q4 2023. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • American Trust held 1,978 shares of Gilead Sciences worth $250K as of Q2 2026.
  • American Trust bought 65 Gilead Sciences shares in Q2 2026, an estimated $8.56K.
  • Gilead Sciences made up 0.02% of American Trust's portfolio in Q2 2026, its #276 holding.
  • American Trust first reported a position in Gilead Sciences in Q1 2023 and has held it in 12 quarters since.
  • American Trust's Gilead Sciences position peaked at $2.95M in Q4 2023.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on American Trust's 13F filing for Q2 2026, filed 14 Aug 2026.